ArticleNPJ vaccines2026

Development of a Prophylactic mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome Using HSA based LNP.

Tsenddari Ganbold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.